Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | CRHBP | P24387 | 2/20 | 0.61 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.50 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.50 |
| ▸ | ITGAL | P20701 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8493018 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL5279172 | 0.82 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL23646856 | 0.81 | SMN1; SMN2 (0.65) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL1890902 | 0.81 | NISCH (0.53) | HTTITGB2ICAM1ITGALNISCH | |
| SCHEMBL2400301 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL625232 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL5522539 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL8746467 | 0.79 | SMN1; SMN2 (0.61) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL11505745 | 0.78 | LMNA (1.00) | SMN1; SMN2LMNACRHBPCRHR2HTT | |
| SCHEMBL10425464 | 0.78 | LMNA (1.00) | SMN1; SMN2LMNACRHBPCRHR2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112229991-B | Nano-capture device and preparation method and application thereof | 厦门圣科环保科技股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| US-20040044210-A1 | Miniaturization; network of hydrogen bonding | PURDUE RESEARCH FOUNDATION | 2004-03-04 | — | — | US | claimed |
| WO-2024006016-A1 | METHOD OF PREPARING FUNCTIONAL POLYMERS | MERICHEM COMPANY (US) | 2024-01-04 | — | — | WO | disclosed |
| US-20230416420-A1 | Method Of Preparing Functional Polymers | MERICHEM COMPANY (US) | 2023-12-28 | — | — | US | disclosed |
| CN-112229991-B | Nano-capture device and preparation method and application thereof | 厦门圣科环保科技股份有限公司 | 2022-08-16 | — | — | CN | disclosed |
| CN-112229991-A | Nano-capture device and preparation method and application thereof | 厦门圣科环保科技股份有限公司 | 2021-01-15 | — | — | CN | disclosed |
| US-9130231-B2 | Lithium ion battery | GM Global Technology Operations LLC (US) | 2015-09-08 | — | — | US | disclosed |
| US-20140329143-A1 | LITHIUM ION BATTERY | GM Global Technology Operations LLC | 2014-11-06 | — | — | US | disclosed |
| US-8785054-B2 | Lithium ion battery | GM Global Technology Operations LLC (US) | 2014-07-22 | — | — | US | disclosed |
| US-8765301-B2 | Lithium ion battery | GM Global Technology Operations LLC (US) | 2014-07-01 | — | — | US | disclosed |
| US-8568930-B2 | Lithium ion battery | GM Global Technology Operations LLC (US) | 2013-10-29 | — | — | US | disclosed |
| US-20120082893-A1 | LITHIUM ION BATTERY | GM Global Technology Operations LLC (US) | 2012-04-05 | — | — | US | disclosed |
| US-20110165459-A1 | LITHIUM ION BATTERY | GM Global Technology Operations LLC (US) | 2011-07-07 | — | — | US | disclosed |
| US-20110151333-A1 | LITHIUM ION BATTERY | GM GLOBAL TECHNOLOGY OPERATIONS, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2008076491-A3 | SENSOR FOR IMPLANTABLE MEDICAL DEVICE | MEDTRONIC INC (US) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008076491-A2 | SENSOR FOR IMPLANTABLE MEDICAL DEVICE | MEDTRONIC, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| US-20040044210-A1 | Miniaturization; network of hydrogen bonding | PURDUE RESEARCH FOUNDATION | 2004-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040044210-A1 | Miniaturization; network of hydrogen bonding | CTCF, MYCBP, APLNR | SMN1; SMN2 4449/4885LMNA 4634/4885CRHBP 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.